vToxiNet: a biologically constrained deep learning framework for interpretable prediction of drug-induced hepatotoxicity
Jia, X.; Wang, T.; Russo, D. P.; Aleksunes, L. M.; Xiao, S.; Zhu, H.
Show abstract
Hepatotoxicity remains a leading cause of drug attrition and post-marketing withdrawal, resulting from diverse and complex toxicity mechanisms. Traditional in vitro models can only capture a limited subset of toxicity pathways, and animal studies face translational and ethical limitations. Regulatory agencies have therefore promoted new approach methodologies, including human-relevant assays, omics technologies, and computational models to improve predictive toxicology and support evidence-based decision-making. However, most machine learning models for hepatotoxicity either rely solely on chemical structure or operate as black boxes, limiting mechanistic interpretability and broader applicability. Here, we introduce the virtual toxicity network (vToxiNet), a biologically constrained deep learning framework that embeds systems toxicology knowledge directly into neural network architecture for interpretable hepatotoxicity prediction. vToxiNet integrates chemical descriptors, high-throughput assay responses, transcriptomic signatures, and Reactome pathway hierarchy to construct a virtual adverse outcome pathway network. Across cross-validation and multiple external validation datasets, vToxiNet demonstrates robust predictive performance and generalizes to previously unseen chemicals. Importantly, interpretation of vToxiNet enables gene and pathway-level attribution, supporting mechanism-informed hazard characterization and chemical prioritization. These results demonstrate that encoding biological hierarchy as architectural constraints enables both predictive accuracy and mechanistic insight, establishing a generalizable framework for modeling complex biological outcomes.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- AnimalGAN: A Generative Adversarial Network Model Alternative to Animal Studies for Clinical Pathology Assessment 96%
- Machine Learning Identifies Novel Candidates for DrugRepurposing in Alzheimer's Disease 94%
- Designing pathways for bioproducing complex chemicals by combining tools for pathway extraction and ranking 93%
Similar papers in this journal
- A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds 94%
- Thinking like a structural biologist: A pocket-based 3D molecule generative model fueled by electron density 92%
- Tales of 1,008 Small Molecules: Phenomic Profiling through Live-cell Imaging in a Panel of Reporter Cell Lines 92%
Similar papers in this journal
- Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology 95%
- Integrative deep learning analysis improves colon adenocarcinoma patient stratification at risk for mortality 90%
- De Novo Exposomic Geospatial Assembly of Chronic Disease Regions with Machine Learning & Network Analysis 89%
Similar papers in this journal
- Multi-behavioral phenotyping in early-life-stage zebrafish for identifying disruptors of non-associative learning 95%
- Genetic variability in pathways associates with pesticide-induced nervous system disease in the United States 89%
- A Data-Driven Transcriptional Taxonomy of Adipogenic Chemicals to Identify White and Brite Adipogens 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.